Osteoporosis and FRAX risk in patients with liver cirrhosis

Osteoporosis and FRAX risk in patients with liver cirrhosis

Background: Hepatic osteodystrophy is any bone disease in patients with chronic liver disease. To measure bone mineral density (BMD) T-score by bone densitometry (BD) is used, classifying the disease in osteopenia, osteoporosis and severe osteoporosis. There are not criteria for monitoring and detec...

Full description

Bibliographic Details
Main Authors: Azucena I. Casanova-Lara, Pilar A. Peniche-Moguel, José L. Pérez-Hernández, Eduardo Pérez-Torres, Galileo Escobedo González, Chantal J. Córdova-Gallardo
Format: Article
Language:English
Published: Permanyer 2014-10-01
Series:Revista Médica del Hospital General de México
Subjects:
Hepatic osteodystrophy
Bone mineral density
Densitometry
FRAX
Osteoporosis
Osteopenia
Online Access:http://www.sciencedirect.com/science/article/pii/S0185106314000316

Internet

http://www.sciencedirect.com/science/article/pii/S0185106314000316

Similar Items